[2021] Infertility Drugs Market Booming With Score Past US$ 6.2 Billion by 2027, Says Coherent Market Insights. Inc

Infertility affects both men and women, making it a global health problem. Female infertility is caused by advanced age, polycystic ovarian syndrome (PCOS), obesity, and multiple miscarriages, while male infertility is caused by erectile dysfunction, low sperm count, irregular sperms, and other factors. Infertility drugs are expected to be in high demand as the rate of infertility rises. Infertility affects one out of every four couples in developing economies, according to a World Health Organization (WHO) study from 2012. Many scientists are trying to find an effective cure for infertility. For example, researchers at Ben-Gurion University (BGU) in Israel were working on a new single-dose infertility treatment based on a new compound in 2018. The new therapy, developed by BGU researchers, increases telomerase expression and re-elongates telomeres, protecting cells from damage.

The global infertility drugs market was worth US$ 3.8 billion in 2019, and it is projected to develop at a CAGR of 5.8% over the forecast period (2020-2027).

Get Full PDF Sample Copy of Report (AVAIL UP-TO 30% OFF) @ https://www.coherentmarketinsights.com/insight/request-sample/2665

Because of the increasing research and development studies for more successful treatments to achieve pregnancy and live births, the infertility drugs market is expected to expand significantly. For example, a team of researchers from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) discovered in 2014 that women taking Letrozole have higher rates of ovulation and live births than women taking Clomiphene. Furthermore, women who received Letrozole had a live birth 27.5 percent of the time, while women who received clomiphene only had a live birth 19.1 percent of the time. The Letrozole group had a higher average ovulation rate, with ovulation occurring 61.7 percent of the time, while the clomiphene group ovulated 48.3 percent of the time.

Furthermore, an increase in the prevalence of lifestyle disorders such as obesity, stress, smoking, diabetes, Poly Cystic Ovarian Syndrome (PCOS), and others, leads to infertility and this is again expanding the market for infertility drugs. In China, smoking was linked to a 15.3 percent decrease in sperm density, 17.5 percent decrease in total sperm counts, and 16.6 percent decrease in total motile sperm, according to a study published in the National Center for Biotechnology and Information (NCBI) 2015 report.

The side effects of infertility drugs, such upper respiratory tract infection, mood swings, pelvic discomfort, headache, abnormal bleeding or spotting, Ovarian Hyper-Stimulation Syndrome (OHSS), sinus congestion, breast tenderness,  injection site pain,  dizziness are limiting the market growth of infertility drugs (OHSS). According to a study published in the National Center for Biotechnology Information in 2016, up to 10% to 20% of women who take infertility drugs will develop a mild type of OHSS that will normally resolve on its own. In the United States, severe cases of OHSS affect less than 1% of patients.

 Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report @
https://www.coherentmarketinsights.com/insight/buy-now/2665

Key players operating in the global infertility drugs market include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories, Bayer AG, and Zydus Pharmaceuticals.

Detailed Segmentation:

By Drug Type:

Clomiphene citrate

Sex hormones

Estrogen

Progesterone

Testosterone

Gonadotropins

Bromocriptine

Cabergoline

Imipramine

Letrozole

Metformin

By Route of Administration:

Oral

Intravenous

Subcutaneous

Intramuscular

By Gender:

Male

Female

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Get Sample PDF Brochure with Impact of COVID19:
https://www.coherentmarketinsights.com/insight/request-pdf/2665

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact us:

Mr. Shah
Senior Client Partner – Business Development
sales@coherentmarketinsights.com